Fred Hutchinson Cancer Center is an independent, nonprofit, unified adult cancer care and research center that is clinically integrated with UW Medicine, a world leader in clinical care, research and learning. The first National Cancer Institute-designated cancer center in the Pacific Northwest, Fred Hutch’s global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy, and COVID-19 vaccines has confirmed our reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Based in Seattle, Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy, and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures to the world’s deadliest diseases and make life beyond cancer a reality.
At Fred Hutch, we believe that the innovation, collaboration, and rigor that result from diversity and inclusion are critical to our mission of eliminating cancer and related diseases. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an antiracist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, antiracism, and inclusion.
The HIV Vaccine Trials Network (HVTN) Laboratory Center is part of an international collaboration of scientists and educators searching for an effective and safe HIV vaccine. The HVTN’s mission is to facilitate the process of testing preventive vaccines against HIV/AIDS. The organization conducts all phases of clinical trials from evaluating experimental vaccines for safety and the ability to stimulate immune responses to testing vaccine efficacy. The Laboratory Center is responsible for carrying out the scientific agenda of the HVTN in determining by laboratory-based studies which vaccine regimens should be advanced for efficacy trials and show promise for licensure. This effort includes leading a number of working groups, committees, specimen repository oversight, assay performance and quality assurance. The HVTN Laboratory Center now plays a similar role in the Coronavirus Prevention Network (CoVPN), evaluating COVID-19 vaccines and conducting observational studies.
The Laboratory Protocol Coordinator I-II is an experienced contributor and will coordinate and support the laboratory studies for the HIV Vaccine Trials Network (HVTN) and Coronavirus Prevention Network protocols (clinical trials). The incumbent works under the direction of the Laboratory Protocol Operations Supervisor. The Laboratory Protocol Coordinator will participate in HVTN conference calls and meetings, prepare written reports and oral presentations, and as necessary, assist with grant applications. They will coordinate with Statistical Center for HIV/AIDS Research and Prevention (SCHARP), protocol teams, clinical trial sites and study sponsors on protocol operations, data transfer, analysis and presentations.
Laboratory Protocol Coordinator I - Master's degree with 1 year or Bachelor's degree with 2 years' experience with expertise in human clinical trials, immunology and/or virology
Laboratory Protocol Coordinator II - Master's degree with 2 years' or Bachelor's degree with 4 years' experience with expertise in human clinical trials, immunology and/or virology
Fred Hutch has a mandatory COVID-19 vaccine requirement, with exceptions only for approved medical or religious accommodations.
As a condition of employment, newly hired employees must provide proof of vaccination or initiate the accommodations process before their first day of employment.
A statement describing your commitment and contributions toward greater diversity, equity, inclusion, and antiracism in your career or that will be made through your work at Fred Hutch is requested of all finalists. #ZR